Warsaw, December 16, 2025
Jutro Medical has just closed a €24 million growth round—one of the largest in Poland and the most significant in healthcare this year. As the lead investor, Warsaw Equity Group is proud to support this ambitious and transformative company, alongside a group of respected co-investors. This funding marks a pivotal moment for both Jutro Medical and the broader Polish healthcare system.
Addressing Critical Healthcare Challenges
For years, Poland’s primary care sector has faced mounting challenges: staff shortages, long queues, and low patient satisfaction. Despite increased public spending, 79% of Poles believe the healthcare system is in crisis or deteriorating. Clinics are overwhelmed, physicians are under pressure, and patients demand faster, more transparent, and consistent care experiences.
Amid these challenges, Jutro Medical stands out. Their unique combination of a scalable growth model—centered on acquiring and modernizing clinics—and advanced in-house technology is already delivering tangible results. Their proprietary EHR system and mobile app automate routine tasks, boost operational efficiency, and enhance care quality. With an NPS, Net Promotor Score, of 86 (compared to an industry average of 46), Jutro Medical is setting new standards for patient satisfaction in Europe.
Our Investment Thesis
At WEG, we support the region’s leading technology-driven companies. We invested in Jutro Medical because we believe they can become the first-choice provider in Polish primary care and, in time, expand their model beyond Poland. We’re backing not just a company, but a vision of accessible, effective, and modern healthcare.
Digitalization and consolidation of primary care are already transforming patient experiences and system efficiency—and we are committed to fueling this progress with both capital and expertise.
We see Jutro Medical as a blueprint for the future of healthcare in Poland and across Central and Eastern Europe:
- Scalable model: Growth through smart acquisitions, not just new builds
- Technology as a differentiator: In-house software that even leading competitors can’t match
- Systemic impact: Lower costs, higher quality, and better access for all stakeholders
To see our full portfolio, check out the Portfolio section.